Medical Journals

Neuroprotective Effects of Melatonin Upon the Offspring Cerebellar Cortex in the Rat Model of Bcnu-induced Cortical Dysplasia.

Authors:
  • Uyanikgil Yiğit
  • Baka Meral
  • Ateş Utku
  • Turgut Mehmet
  • Yavaşoğlu Altuğ
  • Ulker Sibel
  • Sözmen Eser Yildirim
  • Sezer Ebru
  • Elmas Ciğdem
  • Yurtseven Mine Ertem

From: Department of Histology and Embryology, Ege University School of Medicine, TR-35100 Izmir, Turkey.

Brain research

  • Publish Date: Jul 2007
  • ISSN: 0006-8993
  • Volume: 1160
  • Issue:
  • Pages: 134-44
  • Medium: Print
  • Language: English
  • Citation (JAMA): Uyanikgil Yiğit, Baka Meral, Ateş Utku, et al. Neuroprotective Effects of Melatonin Upon the Offspring Cerebellar Cortex in the Rat Model of Bcnu-induced Cortical Dysplasia.. Brain Res. Jul 2007;1160:134-44

Abstract

Cortical dysplasia is a malformation characterized by defects in proliferation, migration and maturation. This study was designed to evaluate the alterations in offspring rat cerebellum induced by maternal exposure to carmustine-[1,3-bis (2-chloroethyl)-1-nitrosoure] (BCNU) and to investigate the effects of exogenous melatonin upon cerebellar BCNU-induced cortical dysplasia, using histological and biochemical analyses. Pregnant Wistar rats were assigned to five groups: intact-control, saline-control, melatonin-treated, BCNU-exposed and BCNU-exposed plus melatonin. Rats were exposed to BCNU on embryonic day 15 and melatonin was given until delivery. Immuno/histochemistry and electron microscopy were carried out on the offspring cerebellum, and levels of malondialdehyde and superoxide dismutase were determined. Histopathologically, typical findings were observed in the cerebella from the control groups, but the findings consistent with early embryonic development were noted in BCNU-exposed cortical dysplasia group. There was a marked increase in the number of TUNEL positive cells and nestin positive cells in BCNU-exposed group, but a decreased immunoreactivity to glial fibrillary acidic protein, synaptophysin and transforming growth factor beta1 was observed, indicating a delayed maturation, and melatonin significantly reversed these changes. Malondialdehyde level in BCNU-exposed group was higher than those in control groups and melatonin decreased malondialdehyde levels in BCNU group (P<0.01), while there were no significant differences in the superoxide dismutase levels between these groups. These data suggest that exposure of animals to BCNU during pregnancy leads to delayed maturation of offspring cerebellum and melatonin protects the cerebellum against the effects of BCNU.

Mesh Headings (Keywords): Animals, Animals, Newborn, Brain Diseases, Bromodeoxyuridine, Carmustine, Cerebellar Cortex, Disease Models, Animal, Female, In Situ Nick-End Labeling, Malondialdehyde, Melatonin, Microscopy, Electron, Transmission, Nerve Tissue Proteins, Neuroprotective Agents, Pregnancy, Prenatal Exposure Delayed Effects, Rats, Rats, Wistar, Superoxide Dismutase, Transforming Growth Factor beta1


Check for Full Text / PubMed Unique Identifier (PMID): 17572393


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.